{"postfix": "qiagen-aktie", "name": "QIAGEN", "wkn": "A2DKCH", "time": "2020.05.26 16:09", "ts": 1590502193, "features": {"KGV": "23.83", "Marktkapitalisierung": {"Size": "Mrd", "Value": "9.04"}, "GA": "1.43", "KBV": "3.12", "BA": "10.94", "KCV": "23.02", "CA": "1.48", "Vola30": "11.45", "Vola90": "37.62", "Vola180": "43.26", "Vola250": "43.48"}, "rivals": ["bb_biotech-aktie", "evotec-aktie", "morphosys-aktie", "agennix-aktie", "amgen-aktie", "roche_2-aktie", "biogen-aktie"], "text_data": {"de": [["09.05.20", "QIAGEN gew\u00e4hrte Anlegern Blick in die B\u00fccher "], ["08.05.20", "Gewinner in der Corona-Krise: Qiagen-Aktie steigt auf 19-Jahres-Hoch"], ["08.05.20", "Qiagen: \u00dcbernahme - geht da noch mehr?"], ["08.05.20", "Wichtige Kursbewegungen: Qiagen-Aktie steigt auf 19-Jahres-Hoch"], ["07.05.20", "Qiagen: 50 mal mehr Corona-Testkits"], ["06.05.20", "Endg\u00fcltige Qiagen-Zahlen ohne \u00dcberraschung"], ["06.05.20", "NACHB\u00d6RSE/XDAX -0,7% auf 10.535 Pkt - Zalando sehr fest"], ["06.05.20", "M\u00c4RKTE EUROPA/R\u00fccksetzer - schwache EU-Prognosen verstimmen"], ["06.05.20", "M\u00c4RKTE EUROPA/B\u00f6rsen drehen ins Minus - schwache EU-Prognosen"], ["06.05.20", "M\u00c4RKTE EUROPA/Anleger trotz schwacher EU-Prognosen vorsichtig optimistisch"], ["06.05.20", "KORREKTUR: M\u00c4RKTE EUROPA/Uneinheitlich - Berichtssaison im Blick"], ["06.05.20", "M\u00c4RKTE EUROPA/Uneinheitlich - Berichtssaison im Blick"], ["06.05.20", "Qiagen: Optimismus f\u00fcr das zweite Quartal - Aktie n\u00e4hert sich \u00dcbernahmeangebot"], ["05.05.20", "Qiagen setzt Jahresausblick aus - Optimismus f\u00fcr zweites Quartal"], ["30.04.20", "QIAGEN-Aktie: Einsch\u00e4tzungen und Kursziele der Analysten im April"], ["28.04.20", "Besonders auff\u00e4llige Insidertransaktionen bei SAP, Dr\u00e4gerwerk & Qiagen"], ["27.04.20", "Biotech-Branche hofft auf Durchbruch bei Corona-Forschungen"], ["15.04.20", "NACHB\u00d6RSE/XDAX unv bei 10.278 Pkt - VW und Qiagen gesucht"], ["14.04.20", "Qiagen: \u00dcber den Erwartungen dank Corona-Tests - H\u00fcrden bei der \u00dcbernahme"], ["09.04.20", "NACHB\u00d6RSE/XDAX +1,1% auf 10.680 Pkt - Tui gefragt"], ["09.04.20", "Qiagen profitiert von Corona-Tests"]], "en": [["18.05.20", "SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of QIAGEN N.V. to Thermo Fisher Scientific Inc. is Fair to Shareholders"], ["12.05.20", "Can Qiagen (QGEN) Run Higher on Rising Earnings Estimates?"], ["07.05.20", "QIAGEN (QGEN) Q1 Earnings Lag Estimates, Operating Margin Up"], ["07.05.20", "Here's How Qiagen Trounced Q1 Estimates"], ["06.05.20", "Qiagen plans 50-fold production hike for COVID-19 testing kits"], ["30.04.20", "QIAGEN (QGEN) Q1 Earnings to Gain on Growing Test Kit Sales"], ["17.04.20", "QIAGEN Launches Assay for Cancer Patients Following FDA's Nod"], ["15.04.20", "QIAGEN (QGEN) Reports Preliminary Revenue Results for Q1"], ["26.03.20", "QIAGEN Releases Coronavirus Test Kit in US on New FDA Policy"], ["24.03.20", "The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics"], ["24.03.20", "Germany's Qiagen starts shipping coronavirus diagnostic tests to United States"], ["24.03.20", "UPDATE 1-Germany's Qiagen starts shipping coronavirus diagnostic tests to United States"], ["24.03.20", "Qiagen begins shipping coronavirus diagnostic tests to United States"], ["24.03.20", "Qiagen begins shipping coronavirus diagnostic tests to United States"], ["19.03.20", "QIAGEN Gets CE Nod for QIAstat-Dx Respiratory SARS-CoV-2 Test"], ["17.03.20", "Qiagen to beef up capacity to produce coronavirus test kits"], ["17.03.20", "Is QIAGEN N.V. (QGEN) Outperforming Other Medical Stocks This Year?"], ["13.03.20", "Qiagen says virus test kit output up 70%, not to blame for U.S. testing delays"], ["11.03.20", "Qiagen boosting production of chemical needed to test for coronavirus"], ["10.03.20", "CORRECTED-Thermo Fisher hires senior Goldman banker as strategy chief after Qiagen deal"], ["10.03.20", "Thermo Fisher hires senior Goldman banker as strategy chief after Qiagen deal"], ["09.03.20", "Zacks.com featured highlights include: LGI Homes, Coherus Biosciences, QIAGEN, Regeneron Pharmaceuticals and Century Communities"], ["05.03.20", "Why Is Qiagen (QGEN) Up 19% Since Last Earnings Report?"], ["04.03.20", "Thermo Fisher (TMO) to Buy Molecular Diagnostics Major QIAGEN"], ["04.03.20", "Will QIAGEN Continue to Surge Higher?"], ["03.03.20", "Here's Why Qiagen Jumped Higher Today"], ["03.03.20", "UPDATE 5-Thermo Fisher agrees to buy genetic tester Qiagen in $11.5 bln deal"], ["03.03.20", "Thermo Fisher agrees to buy genetic tester Qiagen in $11.5 billion deal"], ["03.03.20", "Thermo Fisher buying Qiagen in deal worth about $10.1B"], ["03.03.20", "Thermo Fisher agrees to buy genetic tester Qiagen in $11.5 billion deal"], ["03.03.20", "UPDATE 4-Thermo Fisher agrees to buy genetic tester Qiagen in $11.5 bln deal"], ["03.03.20", "Thermo Fisher makes $11.6B approach for Qiagen"], ["03.03.20", "Thermo Fisher launches $11.6 billion bid for genetic tester Qiagen"], ["03.03.20", "Qiagen shares surge after agreeing to be bought by Thermo Fisher for $11.5 billion"], ["03.03.20", "Thermo Fisher to buy Qiagen in $11.5bn deal"], ["03.03.20", "UPDATE 3-Thermo Fisher launches $11.6 billion bid for genetic tester Qiagen"], ["03.03.20", "UPDATE 2-Thermo Fisher launches $12 bln bid for Qiagen"], ["03.03.20", "UPDATE 1-Thermo Fisher launches $12 billion bid for Qiagen"], ["03.03.20", "Thermo Fisher launches $12 billion bid for Qiagen"], ["03.03.20", "QIAGEN N.V. : Conclusion of a Business Combination Agreement between QIAGEN N.V. and Thermo Fisher Scientific Inc.; Announcement of a public tender offer by Thermo Fisher Scientific Inc."], ["2020-05-26 12:33", "FACTBOX-Global pharma industry steps up efforts to battle coronavirus ... September. May 14 GlaxoSmithKline Plc Partnered with Sanofi SA to develop a vaccine. Sanofi's CEO has Early stage trials said it is vital that any coronavirus vaccine reach all parts of the world, to begin in second after angering the French government earlier by saying some countries would half of 2020. get priority access. DIAGNOSTICS Date of Company Progress Story link last update March 31 Qiagen NV The German company has launched a test in Europe that may detect coronavirus in about an hour. The test is also allowed for use in the United States. May 21 Abbott Laboratories Launched several COVID-19 tests, including one that is used in the White House. March 21 Danaher Corp Company's Cepheid unit has gained U.S. approval for a rapid diagnostic test ... "], ["2020-05-26 12:33", "FACTBOX-Global pharma industry steps up efforts to battle coronavirus ... September. May 14 GlaxoSmithKline Plc Partnered with Sanofi SA to develop a vaccine. Sanofi's CEO has Early stage trials said it is vital that any coronavirus vaccine reach all parts of the world, to begin in second after angering the French government earlier by saying some countries would half of 2020. get priority access. DIAGNOSTICS Date of Company Progress Story link last update March 31 Qiagen NV The German company has launched a test in Europe that may detect coronavirus in about an hour. The test is also allowed for use in the United States. May 21 Abbott Laboratories Launched several COVID-19 tests, including one that is used in the White House. March 21 Danaher Corp Company's Cepheid unit has gained U.S. approval for a rapid diagnostic test ... "], ["2020-05-22 21:15", "Insights Into North America's Biobanks Market 2020, Featuring Key Player Profiles Including Atlanta Biologicals Inc., BioLifeSolutions Inc. And Thermo Fisher Scientific Inc. ... Stem Cell Biobanking5.3.3 Cord Banking5.3.4 DNA/RNA Biobanking5.3.5 Other Services5.4 By Application5.4.1 Regenerative Medicine5.4.2 Drug Discovery5.4.3 Disease Research5.5 Geography 6 COMPETITIVE LANDSCAPE 6.1 Company Profiles Atlanta Biologicals Inc. (Bio-Techne Corporation) Becton, Dickinson and Company BioLifeSolutions Inc. Chart Industries Inc. Hamilton Company Qiagen NV Sigma-Aldrich Inc. (Merck KGaA) STEMCELL Technologies Inc. Thermo Fisher Scientific Inc. VWR International LLC 7 MARKET OPPORTUNITIES AND FUTURE TRENDS For more information about this report visit https://www.researchandmarkets.com/r/gfzh0r About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We ... "], ["2020-05-22 15:30", "Why Is Thermo Fisher (TMO) Up 4.8% Since Last Earnings Report? ...  earnings report in order to get a better handle on the important drivers. Thermo Fisher Beats on Q1 Earnings on Growth In Life Sciences Thermo Fisher's first-quarter 2020 adjusted earnings per share of $2.94 beat the Zacks Consensus Estimate by 5.4%. The figure improved 4.6% year over year. The adjusted number excludes certain non-recurring expenses, QIAGEN acquisitioncosts and certain restructuring costs, net, consisting principally of severance, abandoned facility and other expenses of headcount reductions within several businesses and real estate consolidation. On a reported basis, earnings per share were $1.97, down 2.5% year over year. Revenues in the quarter under review grossed $6.23 billion, up 1.6% year over year. The top line also exceeded ... "], ["2020-05-20 10:03", "Here's Why You Should Hold on to Illumina (ILMN) Stock for Now ... : We are optimistic about Illumina's expansion strategy. It partnered with IDbyDNA in March with the aim of co-marketing IDbyDNA's Explify Platform for use with Illumina's NGS systems and library preparation to provide a complete and streamlined workflow solution for infectious disease applications. Further, Illumina's partnership with QIAGEN is aimed at expanding the accessibility and use of NGS-based IVD kits, including companion diagnostics, for better patient management. The company's collaboration with Adaptive Biotechnologies Corporation will enable clinicians to carry out clinical immunodiagnostic testing, which can be conducted in local laboratories. Downsides Stiff Competition: Illumina faces tough competition in the sequencing ... "], ["2020-05-19 13:15", "Global Bioinformatics Industry Analysis, 2014-2024 Featuring Profiles Of Leading Players Including Illumina, Life Technologies, Qiagen, Agilent Technologies, And PerkinElmer ...  & Developments 13. Competitive Landscape 13.1. Competition Outlook13.2. Company Profiles13.2.1. Company Details13.2.2. Financials (as reported)13.2.3. Key Market Focus and Geographical Presence13.2.4. Pricing of Target Products13.2.5. Market positioning13.3. Global Players Profiled (Leading Companies)13.3.1. Illumina Inc.13.3.2. Life Technologies (Thermo Fischer Scientific)13.3.3. Qiagen N.V.13.3.4. Agilent Technologies13.3.5. PerkinElmer13.3.6. Accelrys Inc.13.3.7. Geneva Bioinformatics S.A.13.3.8. Ontoforce13.3.9. Data4Cure 13.3.10 . Life Map Sciences (Biotime) 14. Strategic Recommendations For more information about this report visit https://www.researchandmarkets.com/r/82c72t Research and Markets also offers Custom Research services providing focused ... "], ["2020-05-19 13:07", "Pier 1 Imports to wind down its business after not finding a buyer ... Celebrity What The Tiny Diamond On A Measuring Tape Is For Livestly Ad Coronavirus stimulus checks: Here's what a second round could look like Yahoo Money Court clears way for execution of inmate Yahoo News Video Vintage Photos Of Celebs On Their Wedding Day Faqtoids.com Ad Global Bioinformatics Industry Analysis, 2014-2024 Featuring Profiles of Leading Players Including Illumina, Life Technologies, Qiagen, Agilent Technologies, and PerkinElmer PR Newswire The sister of Ahmaud Arbery's accused killer posted pictures of his dead body to Snapchat, and said it's because she's a 'true crime fan' INSIDER Trump Just Retweeted One Of His Biggest Critics, Who Replied Exactly How You'd Expect HuffPost New Jersey: Say Bye To Expensive Solar ... "], ["2020-05-19 12:04", "Hydroxychloroquine: Using anti-malaria drug is a risky business ...  evaluated the case files of 368 patients at US hospitals for military veterans. Despite concerns about the methodology of the studies, their significance, and possible side effects, clinical tests with the well-known active substance have now been carried out in other places, too. Read more: Coronavirus: Paper towels and coins beat hand dryers and banknotes Watch video 02:01 Share Qiagen develops rapid test Send Facebook Twitter google+ Whatsapp Tumblr linkedin stumble Digg reddit Newsvine Permalink https://p.dw.com/p/3ZuXT European biotech giant develops sought-after rapid test Fatal study in Brazil A small phase II study in Brazil, in which 11 patients died of fatal arrhythmias or heart muscle damage, shows how risky high-dose treatment of COVID-19 ... "], ["2020-05-19 04:00", "African-American and white women share genes that increase breast cancer risk ...  American Cancer Society; and by the Susan G Komen Foundation (JRP, SMD), Breast Cancer Research Foundation (FJC, CBA, JMW, SMD, KLN), and Karin Grunebaum Cancer Research Foundation (JRP). Note to Editor: The authors have no conflicts of interest. Drs. Couch and Domchek have the following disclosures: Fergus Couch - Honoraria/Speakers Bureau: Ambry Genetics, Qiagen, AstraZeneca; Corporate Sponsored Research: GRAIL. Susan Domchek - Honoraria: AstraZeneca, Clovis, BMS; Corporate-Sponsored Research: The University of Pennsylvania has received research funding for clinical trials from Clovis and AstraZeneca. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of ... "], ["2020-05-19 00:30", "Quidel's Lyra Direct SARS-CoV-2 Assay Receives Emergency Use Authorization And CE Mark For Molecular Detection Of COVID-19, Without Extraction Step ...  requires an up-front sample extraction. The Lyra Direct SARS-CoV-2 Assay uses a reformulated buffer that replaces the extraction step with a simple 10-minute heat step, saving approximately 50 minutes in processing time. The assay retains its versatility in that it is capable of running on any of seven possible thermocyclers (Applied Biosystems 7500 Standard, Applied Biosystems 7500 Fast, Bio-Rad CFX96 Touch, Qiagen Rotor-Gene Q, Roche LightCycler 480, Roche Cobas z480, and Thermo Fisher QuantStudio 7 Pro). 1 Lyra Direct Receives CE Mark Separately, the Lyra Direct SARS-CoV-2 Assay received CE Mark on May 8, 2020. The CE Mark allows Quidel to market and sell the Lyra Direct SARS-CoV-2 Assay in Europe, as well as other countries that accept the CE Mark. The ... "], ["2020-05-18 19:34", "SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of QIAGEN N.V. to Thermo Fisher Scientific Inc. is Fair to ShareholdersNew York, New York--(Newsfile Corp. - May 18, 2020) - The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased QIAGEN N.V. (NYSE: QGEN) (\" QIAGEN \" or the \"Company\") stock prior to May 18,"], ["2020-05-18 18:01", "SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of iQIYI, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 15, 2020 - IQ ...  by email for Levi & Korsinsky, LLP orall companies belonging to the industry. Sign Up Recent News SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Bed Bath & Beyond Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 15, 2020 - BBBY 2020-05-18 4:17 PM ET SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of QIAGEN N.V. to Thermo Fisher Scientific Inc. is Fair to Shareholders 2020-05-18 3:34 PM ET SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of eHealth, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 8, 2020 - EHTH 2020-05-18 2:01 PM ET Company Profile Hashtags NASDAQ Investing Tell Us Your Story Learn More Vancouver 380 - 1100 ... "], ["2020-05-18 18:01", "SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of eHealth, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 8, 2020 - EHTH ...  by email for Levi & Korsinsky, LLP orall companies belonging to the industry. Sign Up Recent News SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Bed Bath & Beyond Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 15, 2020 - BBBY 2020-05-18 4:17 PM ET SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of QIAGEN N.V. to Thermo Fisher Scientific Inc. is Fair to Shareholders 2020-05-18 3:34 PM ET SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of eHealth, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 8, 2020 - EHTH 2020-05-18 2:01 PM ET Company Profile Hashtags NASDAQ Investing Tell Us Your Story Learn More Vancouver 380 - 1100 ... "], ["2020-05-18 13:30", "Deals of the day-Mergers and acquisitions ... Mergers & Acquisitons - Americas May 18, 2020 / 10:05 AM / Updated 38 minutes ago Deals of the day-Mergers and acquisitions 2 Min Read (Updates Thyssenkrupp, Total) May 18 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Monday: ** U.S. life science tools company Thermo Fisher launched its agreed $11.5 billion takeover offer for Qiagen , calling on investors of the German genetic testing specialist to tender their shares. ** German conglomerate Thyssenkrupp is in talks with international rivals about consolidating its loss-making steel business, a person familiar with the matter said. ** French energy group Total said it had agreed to buy up a large customer portfolio from Energas de Portugal and two of EDP' ... "], ["2020-05-18 13:30", "Deals of the day-Mergers and acquisitions ...  Mergers & Acquisitions - Americas May 18, 2020 / 10:02 AM / Updated an hour ago Deals of the day-Mergers and acquisitions 2 Min Read (Updates Thyssenkrupp, Total) May 18 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Monday: ** U.S. life science tools company Thermo Fisher launched its agreed $11.5 billion takeover offer for Qiagen , calling on investors of the German genetic testing specialist to tender their shares. ** German conglomerate Thyssenkrupp is in talks with international rivals about consolidating its loss-making steel business, a person familiar with the matter said. ** French energy group Total said it had agreed to buy up a large customer portfolio from Energas de Portugal and two of EDP' ... "], ["2020-05-18 12:34", "USA-Les valeurs suivre Wall Street (actualis) ...  porter plainte cet t, a rapport vendredi le Wall Street Journal. * T-MOBILE US - Softbank Group est en discussions pour cder \"une partie importante\" de sa participation de 24% dans T-Mobile sa maison-mre Deutsche Telekom, rapporte lundi le Wall Street Journal. * THERMO FISHER a lanc lundi son offre d'achat amicale de 11,5 milliards de dollars sur Qiagen, appelant les investisseurs du spcialiste allemand des tests gntiques apporter leurs titres l'opration. * OCCIDENTAL PETROLEUM - Total a annonc lundi qu'il renonait l'acquisition des actifs d'Occidental Petroleum au Ghana afin de prserver ses marges de manoeuvre financires face la pandmie de coronavirus. * J.C. PENNEY a demand vendredi bnficier de la protection de la loi sur ... "], ["2020-05-18 11:29", "BRIEF-Thermo Fisher Scientific Publishes Offer Document For Voluntary Tender Offer For All Ordinary Shares Of Qiagen N.V. ...  Politics TV More United States Healthcare May 18, 2020 / 11:29 AM / Updated 38 minutes ago BRIEF-Thermo Fisher Scientific Publishes Offer Document For Voluntary Tender Offer For All Ordinary Shares Of Qiagen N.V. 1 Min Read May 18 (Reuters) - Thermo Fisher Scientific: * THERMO FISHER SCIENTIFIC PUBLISHES OFFER DOCUMENT FOR VOLUNTARY TENDER OFFER FOR ALL ORDINARY SHARES OF QIAGEN N.V. * THERMO FISHER SCIENTIFIC INC - TRANSACTION EXPECTED TO CLOSE IN FIRST HALF OF 2021 * THERMO FISHER SCIENTIFIC INC - ACCEPTANCE PERIOD FOR CASH OFFER OF EUR 39 PER QIAGEN SHARE RUNS FROM MAY 18, 2020, TO JULY 27, 2020 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com) Our Standards: The Thomson Reuters Trust Principles. 0 : 0 narrow-browser ... "], ["2020-05-18 11:29", "BRIEF-Thermo Fisher Scientific Publishes Offer Document For Voluntary Tender Offer For All Ordinary Shares Of Qiagen N.V. ...  World UK TV More United Kingdom Healthcare May 18, 2020 / 11:30 AM / Updated 42 minutes ago BRIEF-Thermo Fisher Scientific Publishes Offer Document For Voluntary Tender Offer For All Ordinary Shares Of Qiagen N.V. 1 Min Read May 18 (Reuters) - Thermo Fisher Scientific: * THERMO FISHER SCIENTIFIC PUBLISHES OFFER DOCUMENT FOR VOLUNTARY TENDER OFFER FOR ALL ORDINARY SHARES OF QIAGEN N.V. * THERMO FISHER SCIENTIFIC INC - TRANSACTION EXPECTED TO CLOSE IN FIRST HALF OF 2021 * THERMO FISHER SCIENTIFIC INC - ACCEPTANCE PERIOD FOR CASH OFFER OF EUR 39 PER QIAGEN SHARE RUNS FROM MAY 18, 2020, TO JULY 27, 2020 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com) Our Standards: The Thomson Reuters Trust Principles. 0 : 0 narrow-browser ... "], ["2020-05-18 09:46", "Thermo Fisher launches 39 euros/share bid for Qiagen ... 's management, in turn, reaffirmed its backing of the transaction in a detailed \"Reasoned Position Statement\" on Monday. The shares were up 0.9% at 39.41 euros at 0925 GMT. (Reporting by Ludwig Burger; Editing by Michelle Martin) What to Read Next Thermo Fisher Scientific Publishes Offer Document for Voluntary Tender Offer for All Ordinary Shares of QIAGEN N.V. PR Newswire Driving less lately? Pay less for coverage. PolicyPilot Ad 12 health-care stocks that will be winners because of coronavirus-led trends, according to Jefferies MarketWatch People Are Worried About Michael Jordan's Eyes In 'The Last Dance' Marie Claire Dow Jones Futures: Apple, Facebook, Google Near Buy Points In Coronavirus Market Rally; The Ultimate Tesla Debate ... "], ["2020-05-18 09:46", "Thermo Fisher launches 39 euros/share bid for QiagenU.S. life science tools company Thermo Fisher on Monday launched its agreed $11.5 billion takeover offer for Qiagen, calling on investors of the German genetic testing specialist to tender their shares."]]}}